Monthly Archives: July 2026

Indiana University and PharmatrophiX Present Findings on Performance of Oral Therapeutic, LM11A-31, to Reduce Decline of Brain Functional-Network Connectivity in Alzheimer’s Disease

• Posted on Jul 13, 2026

New findings presented at featured research session (FRS) during the Alzheimer’s Association International Conference demonstrate statistically significant slowing of decline in brain network function with LM11A-31 vs placebo linked to cognitive domains and synaptic resilience MENLO PARK, California (July 13, 2026) – Indiana University and PharmatrophiX, a privately-held, clinical-stage biopharmaceutical company pioneering the development of ... Read More